Jack Lawler
Directeur Technique/Scientifique/R&D chez CHEMOMAB THERAPEUTICS LTD.
Profil
Jack Lawler is currently the VP-Global Clinical Development Operations at Chemomab Therapeutics Ltd.
He previously worked as the VP-Clinical Operations & Data Management at Goldfinch Bio, Inc. Mr. Lawler completed his undergraduate degree at Rosemont College.
Postes actifs de Jack Lawler
| Sociétés | Poste | Début |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Directeur Technique/Scientifique/R&D | 04/01/2022 |
Anciens postes connus de Jack Lawler
| Sociétés | Poste | Fin |
|---|---|---|
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Jack Lawler
| Rosemont College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
